New Delhi, Jan. 3 -- Diabetes has long been associated with higher cancer risk. But can diabetes medications, which control blood sugar levels and body weight, influence how cancers grow, spread, or slow down?

Researchers are now unravelling how diabetes medications affect immune function, inflammation, and tumour biology, with intriguing but still uncertain implications.

According to Science Daily, a recent review examined how widely used treatments such as metformin, SGLT2 inhibitors, and GLP-1 receptor agonists may affect cancer growth by changing how cells multiply, how the immune system responds, and how inflammation develops.

These insights point to possible new treatment strategies while also highlighting how much remains unknow...